Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $4.8B | $4.6B | $5.3B | $1.2B | $1.4B | |
| Gross Profit | $1.4B | $1.3B | $1.4B | $379.6M | $372.4M | |
| Operating Income | $550.3M | $526.5M | $509.7M | $180.3M | $137.7M | |
| EBITDA | $683.3M | $650.8M | $670.7M | $209.3M | $179.3M | |
| Diluted EPS | $8.01 | $7.70 | $6.55 | $2.37 | $1.91 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.1B | $2.5B | $2.9B | $3.1B | $2.5B | |
| Total Assets | $3.2B | $3.7B | $4.2B | $4.5B | $4.8B | |
| Current Liabilities | $632.5M | $728M | $613.6M | $681M | $835.3M | |
| Total Liabilities | $903.1M | $977M | $862.3M | $902.6M | $1.1B | |
| Total Equity | $2.3B | $2.8B | $3.3B | $3.6B | $3.7B | |
| Total Debt | $174.6M | $150.9M | $135.8M | $127.9M | $114.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $577.3M | $600.3M | $502.3M | $242M | $294.7M | |
| Cash From Investing | -$79.2M | -$59.8M | -$880M | $34.7M | -$9.3M | |
| Cash From Financing | -$133.4M | -$414M | -$436.6M | -$53.5M | -$85.7M | |
| Free Cash Flow | $537.4M | $573.9M | $459.1M | $237M | $286.4M | |
EPAM Systems, Inc. engages in the provision of digital engineering, cloud, and artificial intelligence-enabled transformation services. The firm combines software engineering with customer experience design, business consulting, strategy, and technology innovation services in areas such as cloud platforms, cybersecurity, and artificial intelligence. It operates through the North America and Europe geographical segments. The company was founded by Leonid Lozner and Arkadiy Dobkin in 1993 and is headquartered in Newtown, PA.
In the current month, EPAM has received 10 Buy ratings 5 Hold ratings, and 0 Sell ratings. The EPAM average analyst price target in the past 3 months is $210.82.
According to analysts, the consensus estimate is that EPAM Systems, Inc. share price will rise to $210.82 per share over the next 12 months.
Analysts are divided on their view about EPAM Systems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that EPAM Systems, Inc. is a Sell and believe this share price will drop from its current level to $160.00.
The price target for EPAM Systems, Inc. over the next 1-year time period is forecast to be $210.82 according to 15 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for EPAM Systems, Inc. is a Buy. 10 of 15 analysts rate the stock a Buy at this time.
You can purchase shares of EPAM Systems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase EPAM Systems, Inc. shares.
EPAM Systems, Inc. was last trading at $209.22 per share. This represents the most recent stock quote for EPAM Systems, Inc.. Yesterday, EPAM Systems, Inc. closed at $209.08 per share.
In order to purchase EPAM Systems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.